Cargando…
Cancer Vaccines Based on Fluorine-Modified KH-1 Elicit Robust Immune Response
KH-1 is a tumor-associated carbohydrate antigen (TACA), which serves as a valuable target of antitumor vaccines for cancer immunotherapies. However, most TACAs are thymus-independent antigens (TD-Ag), and they tend to induce immunological tolerance, leading to their low immunogenicity. To overcome t...
Autores principales: | Liu, Yang, Li, Bohan, Zheng, Xiujing, Xiong, Decai, Ye, Xinshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963332/ https://www.ncbi.nlm.nih.gov/pubmed/36838925 http://dx.doi.org/10.3390/molecules28041934 |
Ejemplares similares
-
Drug Discovery Based on Fluorine-Containing Glycomimetics
por: Wei, Xingxing, et al.
Publicado: (2023) -
A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model
por: Song, Chengcheng, et al.
Publicado: (2017) -
The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis
por: Palzer, Kim-Alicia, et al.
Publicado: (2022) -
Synthesis of KH550-Modified Hexagonal Boron Nitride Nanofillers for Improving Thermal Conductivity of Epoxy Nanocomposites
por: Tang, Bolin, et al.
Publicado: (2023) -
032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
por: Balmert, S.C., et al.
Publicado: (2021)